Risk analysis of analytical validations by probabilistic modification of FMEA

► FMEA is a valuable addition to analytical validation. ► Traditional FMEA is modified by replacing categorical scores by probabilities. ► Probabilistic modification of FMEA has added values. ► Frequencies of occurrence of undetected failure modes are now quantified. Risk analysis is a valuable addi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2012-05, Vol.64-65, p.82-86
Hauptverfasser: Barends, D.M., Oldenhof, M.T., Vredenbregt, M.J., Nauta, M.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue
container_start_page 82
container_title Journal of pharmaceutical and biomedical analysis
container_volume 64-65
creator Barends, D.M.
Oldenhof, M.T.
Vredenbregt, M.J.
Nauta, M.J.
description ► FMEA is a valuable addition to analytical validation. ► Traditional FMEA is modified by replacing categorical scores by probabilities. ► Probabilistic modification of FMEA has added values. ► Frequencies of occurrence of undetected failure modes are now quantified. Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.
doi_str_mv 10.1016/j.jpba.2012.02.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_964192019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708512000891</els_id><sourcerecordid>964192019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-5d9596c114b4445046076a88f6599d74e98476fc3c639ddb1ee170b311432f33</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-AQ-Si3hKnc1-JAteSmlVaBGkB2_LZncDG9OkZtNC_70bUvUmDMzAPO8wPAjdYphiwPyxnJa7XE0TwMkUQoE4Q2OcpSROOP04R2NICY5TyNgIXXlfAgDDgl6iUZJQDAySMVq_O_8ZqVpVR-981BTD3DmtquigKmdU55raR_kx2rVNrnJXOR_W0bYxrghYv-5zy_Vido0uClV5e3PqE7RZLjbzl3j19vw6n61iTTLWxcwIJrjGmOaUUgaUQ8pVlhWcCWFSakVGU15oojkRxuTYWpxCTkKAJAUhE_QwnA0ffe2t7-TWeW2rStW22XspOMUiaBGBTAZSt433rS3krnVb1R4lBtlLlKXsJcpeooRQ0IfuTuf3-daa38iPtQDcnwDlg6eiVbV2_o9jGcY867mngbPBxcHZVnrtbK2tca3VnTSN---Pbwbtjnc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>964192019</pqid></control><display><type>article</type><title>Risk analysis of analytical validations by probabilistic modification of FMEA</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Barends, D.M. ; Oldenhof, M.T. ; Vredenbregt, M.J. ; Nauta, M.J.</creator><creatorcontrib>Barends, D.M. ; Oldenhof, M.T. ; Vredenbregt, M.J. ; Nauta, M.J.</creatorcontrib><description>► FMEA is a valuable addition to analytical validation. ► Traditional FMEA is modified by replacing categorical scores by probabilities. ► Probabilistic modification of FMEA has added values. ► Frequencies of occurrence of undetected failure modes are now quantified. Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2012.02.009</identifier><identifier>PMID: 22410502</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Analytical validation ; Analytical, structural and metabolic biochemistry ; Biological and medical sciences ; Chemistry Techniques, Analytical - methods ; Chemistry Techniques, Analytical - statistics &amp; numerical data ; Counterfeit Drugs - analysis ; FMEA ; Fundamental and applied biological sciences. Psychology ; General pharmacology ; Human factor ; Medical sciences ; Models, Statistical ; NIR ; Pharmacology. Drug treatments ; Reproducibility of Results ; Risk analysis ; Risk Assessment - methods ; Risk Assessment - statistics &amp; numerical data ; Spectroscopy, Near-Infrared - methods ; Tablets - analysis</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2012-05, Vol.64-65, p.82-86</ispartof><rights>2012 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-5d9596c114b4445046076a88f6599d74e98476fc3c639ddb1ee170b311432f33</citedby><cites>FETCH-LOGICAL-c385t-5d9596c114b4445046076a88f6599d74e98476fc3c639ddb1ee170b311432f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpba.2012.02.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25811682$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22410502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barends, D.M.</creatorcontrib><creatorcontrib>Oldenhof, M.T.</creatorcontrib><creatorcontrib>Vredenbregt, M.J.</creatorcontrib><creatorcontrib>Nauta, M.J.</creatorcontrib><title>Risk analysis of analytical validations by probabilistic modification of FMEA</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>► FMEA is a valuable addition to analytical validation. ► Traditional FMEA is modified by replacing categorical scores by probabilities. ► Probabilistic modification of FMEA has added values. ► Frequencies of occurrence of undetected failure modes are now quantified. Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.</description><subject>Analysis</subject><subject>Analytical validation</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Biological and medical sciences</subject><subject>Chemistry Techniques, Analytical - methods</subject><subject>Chemistry Techniques, Analytical - statistics &amp; numerical data</subject><subject>Counterfeit Drugs - analysis</subject><subject>FMEA</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General pharmacology</subject><subject>Human factor</subject><subject>Medical sciences</subject><subject>Models, Statistical</subject><subject>NIR</subject><subject>Pharmacology. Drug treatments</subject><subject>Reproducibility of Results</subject><subject>Risk analysis</subject><subject>Risk Assessment - methods</subject><subject>Risk Assessment - statistics &amp; numerical data</subject><subject>Spectroscopy, Near-Infrared - methods</subject><subject>Tablets - analysis</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbK3-AQ-Si3hKnc1-JAteSmlVaBGkB2_LZncDG9OkZtNC_70bUvUmDMzAPO8wPAjdYphiwPyxnJa7XE0TwMkUQoE4Q2OcpSROOP04R2NICY5TyNgIXXlfAgDDgl6iUZJQDAySMVq_O_8ZqVpVR-981BTD3DmtquigKmdU55raR_kx2rVNrnJXOR_W0bYxrghYv-5zy_Vido0uClV5e3PqE7RZLjbzl3j19vw6n61iTTLWxcwIJrjGmOaUUgaUQ8pVlhWcCWFSakVGU15oojkRxuTYWpxCTkKAJAUhE_QwnA0ffe2t7-TWeW2rStW22XspOMUiaBGBTAZSt433rS3krnVb1R4lBtlLlKXsJcpeooRQ0IfuTuf3-daa38iPtQDcnwDlg6eiVbV2_o9jGcY867mngbPBxcHZVnrtbK2tca3VnTSN---Pbwbtjnc</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>Barends, D.M.</creator><creator>Oldenhof, M.T.</creator><creator>Vredenbregt, M.J.</creator><creator>Nauta, M.J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120501</creationdate><title>Risk analysis of analytical validations by probabilistic modification of FMEA</title><author>Barends, D.M. ; Oldenhof, M.T. ; Vredenbregt, M.J. ; Nauta, M.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-5d9596c114b4445046076a88f6599d74e98476fc3c639ddb1ee170b311432f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analysis</topic><topic>Analytical validation</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Biological and medical sciences</topic><topic>Chemistry Techniques, Analytical - methods</topic><topic>Chemistry Techniques, Analytical - statistics &amp; numerical data</topic><topic>Counterfeit Drugs - analysis</topic><topic>FMEA</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General pharmacology</topic><topic>Human factor</topic><topic>Medical sciences</topic><topic>Models, Statistical</topic><topic>NIR</topic><topic>Pharmacology. Drug treatments</topic><topic>Reproducibility of Results</topic><topic>Risk analysis</topic><topic>Risk Assessment - methods</topic><topic>Risk Assessment - statistics &amp; numerical data</topic><topic>Spectroscopy, Near-Infrared - methods</topic><topic>Tablets - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barends, D.M.</creatorcontrib><creatorcontrib>Oldenhof, M.T.</creatorcontrib><creatorcontrib>Vredenbregt, M.J.</creatorcontrib><creatorcontrib>Nauta, M.J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barends, D.M.</au><au>Oldenhof, M.T.</au><au>Vredenbregt, M.J.</au><au>Nauta, M.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk analysis of analytical validations by probabilistic modification of FMEA</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2012-05-01</date><risdate>2012</risdate><volume>64-65</volume><spage>82</spage><epage>86</epage><pages>82-86</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>► FMEA is a valuable addition to analytical validation. ► Traditional FMEA is modified by replacing categorical scores by probabilities. ► Probabilistic modification of FMEA has added values. ► Frequencies of occurrence of undetected failure modes are now quantified. Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22410502</pmid><doi>10.1016/j.jpba.2012.02.009</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2012-05, Vol.64-65, p.82-86
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_964192019
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Analysis
Analytical validation
Analytical, structural and metabolic biochemistry
Biological and medical sciences
Chemistry Techniques, Analytical - methods
Chemistry Techniques, Analytical - statistics & numerical data
Counterfeit Drugs - analysis
FMEA
Fundamental and applied biological sciences. Psychology
General pharmacology
Human factor
Medical sciences
Models, Statistical
NIR
Pharmacology. Drug treatments
Reproducibility of Results
Risk analysis
Risk Assessment - methods
Risk Assessment - statistics & numerical data
Spectroscopy, Near-Infrared - methods
Tablets - analysis
title Risk analysis of analytical validations by probabilistic modification of FMEA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A14%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20analysis%20of%20analytical%20validations%20by%20probabilistic%20modification%20of%20FMEA&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Barends,%20D.M.&rft.date=2012-05-01&rft.volume=64-65&rft.spage=82&rft.epage=86&rft.pages=82-86&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/j.jpba.2012.02.009&rft_dat=%3Cproquest_cross%3E964192019%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=964192019&rft_id=info:pmid/22410502&rft_els_id=S0731708512000891&rfr_iscdi=true